Myo-inositol at High Concentration Reduced Viability and Proliferation of Rat Bone Marrow Mesenchymal Stem Cells via Electrolyte Imbalance and Elevation of Aerobic Metabolism

Document Type: Research Article


Department of Biology, Faculty of Sciences, Arak University, Arak, Iran


Myo-inositol (MI) which is produced at low concentration is an essential substance for animal’s natural growth. This study was performed to investigate the effects of MI on viability, proliferation and some biochemical factors of rat bone marrow mesenchymal stem cells (BMSCs). To investigate the cell viability using trypan blue assay, BMSCs after third passage were treated with different concentration of MI at 12, 24 and 36 hours. Then the samples were treated with 160 and 1280 µM of MI as selected concentrations for 36 hours to carry out further analysis including the proliferation ability via colony forming assay (CFA), publish doubling number (PDN) and the cells morphology. The level of Na+ and K+ was measured by flame photometer. In addition, the activity of ALP, LDH, AST, ALT as well as calcium concentration was evaluated using commercial kits. Data were evaluated using ANOVA, Tukey's test and p2+ level. High concentration of MI not only reduces cell viability via imbalance of electrolytes but also changed the cell morphology. In addition, we observed the elevation of aerobic metabolism via calcium dependent mechanism.


Angeloff LG, Skoryna, SC, Henderson IW. 1977. Effects of the hexahydroxyhexane myoinositol on bone uptake of radiocalcium in rats: Effect of inositol and vitamin D2 on bone uptake of 45Ca in rats. Acta Pharmacol Toxicol (Copenh) 40(2): 209-215.

Arriero MdelM, Ramis JM, Perelló J, Monjo M. 2012. Differential response of MC3T3-E1 and human mesenchymal stem cells to inositol hexakisphosphate. Cell Physiol Biochem 30(4): 974-86.

Bortner CD, Cidlowski JA. 1998. A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol 56(12): 1549-1559.

Chen NX, Ryder KD, Pavalko FM, Turner CH, Burr DB, Qiu J, et al. 2000. Ca (2+) regulates fluid shear-induced cytoskeletal reorganization and gene expression in osteoblasts. Am J Physiol Cell Physiol 278(5): C989-997.

Dai Z, Chung SK, Miao D, Lau KS, Chan AWH, Kung AWC. 2011. Sodium/ myo inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation. J Bone Miner Res 26: 582-590.

Elmore S. 2007. Apoptosis: a review of programmed cell death. Toxicologic Pathology 35:495-516.

Freethi R, Velayutha RA, Ponniraivan K, Rasheed KM, Sundhararajan A. 2016. Study of serum levels of calcium, phosphorus and alkaline phosphatase in chronic kidney disease. Int J Med Res Health Sci 5(3): 49-56.

Gladden LB. 2008. 200th anniversary of lactate research in muscle. Exerc Sport Sci Rev 36(3): 109-115.

Gomes BC, Kaufman HW, Archard, HO, Cangemi C, Guerra A. 1986. Histologic study of the inhibition of bone resorption in organ cultures by myo-inositol-2-monophosphate. J Oral Pathol 15(1): 54-58.

Görlach A, Bertram K, Hudecova S, Krizanova O. 2015. Calcium and ROS: a mutual interplay. Redox Biol 6: 260- 271.

Hager K, Hazama A, Kwon HM, Loo DDF, Handler JS, Wright EM. 1995. Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus oocytes. J Membr Biol 143(2): 103–113.

James J, Ellinger IA, Lewis JL. 2011. Markley. Role of aminotransferases in glutamate metabolism of human erythrocytes. J Biomol NMR 49(3-4): 221-229.

Kuroki M, Satoh H, Kamo N, Kobatake Y. 1981. Contribution to the membrane potential of the electrogenic Na+, K+ pump in guinea pig polymorphonuclear leukocytes. FEBS Lett 123(2): 177-180.

Liu YZ, Wilson SG, Wang L, Liu XG, Guo YF, Li J, et al. 2008. Identification of PLCL1 gene for hip bone size variation in females in a genomewide association study. PloS One 3(9): e3160.

Lopez-Gonzalez, AA, Grases F, Roca P, Mari B, Vicente-Herrero MT, Costa-Bauza A. 2008. Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis. J Med Food 11(4): 747-752.

Marion NW, Mao JJ. 2006. Mesenchymal stem cells and tissue engineering. Methods Enzymol 420: 339-361.

Reynolds TB. 2009. Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it. Microbiol 155: 1386-1396.

Soltani L, Kafilzadeh F, Karami Shabankareh H. 2012. The effect of various concentrations of myo-inositol in culture medium on development of bovine embryos. Iran J Reprod Med 10(5): 409-412.

Stephens LR, Irvine RF. 1990. Stepwise phosphorylation of myo-inositol leading to myo-inositol hexakisphosphate in Dictyostelium. Nature 346: 580-583.

Tran SL, Puhar A, Ngo-Camus M, Ramarao N. 2011. Trypan blue dye enters viable cells incubated with the pore-forming toxin HlyII of Bacillus cereus. PloS One 6(9): e22876.

Wu1 T, LiuI Y, Wangl B, Li1 G. 2014. The roles of mesenchymal stem cells in tissue repair and disease modification. Current Stem Cell Researchs Therapy 9: 424-431.

Zhang J, Liu X, Scherer DC, Kaer L, Wang X, Xu M. 1998. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc Natl Acad Sci 95:12480-12485.